Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer
Molecular Cell · 2026-01 · 86 (1) · 150-165.e9
DOI: 10.1016/j.molcel.2025.12.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026-01. Verfasst von Lingzhi Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Drug Clinical Trial Center, Shanghai Xuh…. Hauptthemen laut MEDLINE: Glutamine, Mitochondria, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Fudan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Oxidative phosphorylation (OXPHOS) fulfills energy metabolism and biosynthesis through the tricarboxylic acid (TCA) cycle and an intact electron transport chain (ETC). Mitochondrial glutamine import (MGI) replenishes the TCA cycle through glutaminolysis, but its broader roles in cancer remain unclear. Here, we show that MGI sustains OXPHOS independently of glutaminolysis by maintaining ETC integrity. Exogenous glutamate availability abrogates cellular dependence on glutaminolysis but not SLC1A5var-mediated MGI. Blocking MGI elicits severe mitochondrial defects, reducing mitochondrial glucose oxidation and increasing glutamine reductive carboxylation. MGI, but not glutaminolysis, is essential for mitochondrial translation by enabling biogenesis of Gln-mt-tRNAGln, the most limiting mitochondrial aminoacyl-tRNA in cancer cells. Finally, deleting SLC1A5 in mice and targeting SLC1A5var in xenograft tumors inhibit Gln-mt-tRNAGln biogenesis and mitochondrial translation and blunt tumor growth. Our findings uncover a previously unrecognized role of MGI in safeguarding ETC integrity independently of glutaminolysis and inform a therapeutic option by targeting MGI to abrogate OXPHOS for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Drug Clinical Trial Center, Shanghai Xuhui Central Hospital, Institute of Clinical Mass Spectrometry, Shanghai…
- Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai 201203, China.
- Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Frontier Innovation Center, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Förderung
- National Key Research and Development Program of China
- Fudan University
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhu, L., Wu, K., You, J., Mi, W., Xu, J., Li, L., Yang, F., Xia, X., Yan, H., Li, F., Chen, L., Liu, P., & Li, F. (2026). Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer. Molecular Cell, 86(1), 150-165.e9. https://doi.org/10.1016/j.molcel.2025.12.001
Vancouver
Zhu L, Wu K, You J, Mi W, Xu J, Li L, et al. Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer. Molecular Cell. 2026;86(1):150-165.e9. doi:10.1016/j.molcel.2025.12.001
BibTeX
@article{Zhu2026,
author = {Zhu, Lingzhi and Wu, Kuishen and You, Jianwei and Mi, Wen and Xu, Jie and Li, Liucheng and Yang, Fang and Xia, Xinyi and Yan, Haohang and Li, Fei and Chen, Li and Liu, Pingyu and Li, Fuming},
title = {Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer},
journal = {Molecular Cell},
year = {2026},
volume = {86},
number = {1},
pages = {150--165.e9},
doi = {10.1016/j.molcel.2025.12.001}
}
EUVIMED